September 13, 2023
Article
Recent advancements in treatment options for patients with diffuse large B-cell lymphoma have been practice-changing.
June 08, 2023
Treatments with JAK inhibitors are continuing to make their way into the MPN space, providing symptom relief, but not yet a cure.
April 12, 2023
Treatment for patients with non-small cell lung cancer has evolved to include immunotherapy after surgery and chemotherapy.
December 19, 2022
Biliary duct cancer, or cholangiocarcinoma, has always been known as a difficult-to-treat disease, but immunotherapies may make an impact on patients' lives.
The Benefit of Clinical Trial Enrollment for Patients With Cancer
Addressing Gaps, Challenges and Disparities in AYA Cancer Care
Unexpected Challenges 11 Years After Breast Cancer
Camrelizumab Combo Doubles 5-Year Survival in Phase 3 Lung Cancer Trial